Name | β-D-Glucopyranoside, (3β,12β)-12-hydroxy-20-[(6-O-β-D-xylopyranosyl-β-D-glucopyranosyl)oxy]dammar-24-en-3-yl O-β-D-xylopyranosyl-(1→2)-O-β-D-glucopyranosyl-(1→2) |
---|---|
Synonyms |
β-D-Glucopyranoside, (3β,12β)-12-hydroxy-20-[(6-O-β-D-xylopyranosyl-β-D-glucopyranosyl)oxy]dammar-24-en-3-yl O-β-D-xylopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->2)-
Dammarane, β-D-glucopyranoside deriv. (3β,12β)-12-Hydroxy-20-{[6-O-(β-D-xylopyranosyl)-β-D-glucopyranosyl]oxy}dammar-24-en-3-yl β-D-xylopyranosyl-(1->;2)-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside Notoginsenoside Fc |
Description | Notoginsenoside Fc, a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation. Notoginsenoside Fc can accelerate reendothelialization following vascular injury in diabetic rats by promoting autophagy[1]. |
---|---|
Related Catalog | |
In Vitro | Notoginsenoside Fc (20 μM; for 24 h) markedly upregulates the expression of LC3B and Beclin 1 and downregulated that of p62 in RAOECs[1]. |
In Vivo | Notoginsenoside Fc (3.5 mg/kg/day) accelerates reendothelialization and alleviates excessive neointimal formation following carotid artery injury in diabetic Sprague-Dawley rats (200±20 g) in vivo[1]. |
References |
Density | 1.47±0.1 g/cm3 |
---|---|
Molecular Formula | C58H98O26 |
Molecular Weight | 1211.383 |
Exact Mass | 1210.634644 |
PSA | 415.98000 |
LogP | 6.60 |
Index of Refraction | 1.631 |
Water Solubility | Insuluble (1.9E-3 g/L) (25 ºC) |